Ce înseamnă „Clear”?
Animalul nu poartă mutația. Nu va dezvolta boala și nu o va transmite mai departe.
Discover the essential DNA test for Canine Scott Syndrome in dogs, a rare inherited disorder affecting cardiac and neurological health. Early detection through genetic testing allows veterinarians and breeders to identify carriers and affected dogs, promoting healthier breeding decisions. The Canine Scott Syndrome DNA test provides accurate, reliable results, helping prevent the spread of this hereditary condition. Protect your dog's well-being by screening for genetic disorders with the latest canine DNA testing services. Knowledge of your dog's genetic health ensures better management and improves quality of life. Stay informed—choose a reputable DNA test to detect Canine Scott Syndrome today. Ensure your dog’s future health with comprehensive genetic testing.
Platelet Factor X Receptor Deficiency
Canine Scott Syndrome is a rare inherited disorder affecting dogs, characterized by a deficiency in platelet function. This condition leads to increased bleeding and easy bruising, often presenting in young dogs. A DNA test can accurately diagnose the syndrome by identifying specific genetic mutations. Early detection allows veterinarians to manage symptoms effectively and prevent complications. Regular testing is recommended for breeds known to carry the mutation.
Acest test ADN este inclus începând din pachetul nostru Basic — și face parte și din pachete Basic, Standard, Advanced, Complete.
Vizualizați pachetele de teste ADN →Canine Scott Syndrome is a rare inherited bleeding disorder that affects dogs, characterized by a deficiency in platelet function. Unlike other bleeding disorders that result from a decrease in platelet count, Scott Syndrome involves a defect in the ability of platelets to expose phosphatidylserine on their surface, which is essential for proper blood clotting. This defect impairs the blood's ability to form stable clots, leading to an increased risk of bleeding episodes.
The condition is inherited in an autosomal recessive manner, meaning that a dog must inherit two copies of the mutated gene—one from each parent—to be affected. Carriers, with only one copy of the mutation, usually do not exhibit symptoms but can pass the gene to offspring. The genetic mutation responsible for Scott Syndrome affects the pathways involved in platelet activation and phospholipid scrambling, crucial processes in the coagulation cascade.
Dogs affected by Scott Syndrome typically present with easy bruising, spontaneous bleeding, prolonged bleeding after injuries or surgeries, and in some cases, bleeding into joints or tissues. The severity of symptoms can vary depending on the extent of platelet dysfunction. Often, affected dogs may not show signs until an injury occurs or during surgical procedures, when bleeding complications become evident.
The DNA test for Scott Syndrome plays a vital role in identifying carriers and affected dogs, facilitating informed breeding decisions to prevent the spread of the disorder. Early diagnosis through genetic testing allows veterinarians and breeders to implement appropriate management strategies, such as avoiding trauma, planning for potential bleeding complications during surgeries, and reducing the incidence of affected puppies in the population. It also helps in understanding the prevalence of the condition within specific breeds or bloodlines.
Testing can confirm whether a dog is affected, a carrier, or clear of the mutation. An affected dog requires careful medical management to prevent bleeding episodes, especially during surgeries or injuries. Carriers are generally asymptomatic but should be considered in breeding programs to prevent passing the mutation to offspring. Dogs that test clear are not at risk of developing or passing on the disorder, contributing to healthier bloodline management.
DNA testing for Canine Scott Syndrome is an essential tool for responsible breeding and health management. By accurately identifying affected dogs and carriers, owners and breeders can make informed decisions that promote canine health and reduce the prevalence of this inherited bleeding disorder in the dog population.
Animalul nu poartă mutația. Nu va dezvolta boala și nu o va transmite mai departe.
Nu. Animalul este în general sănătos, dar poate transmite mutația acestuia urmas.
Are două copii mutante. Se așteaptă semne clinice în funcție de boala. Nu trebuie crescut.
Unele boli sunt legate de sex, astfel încât expresia lor variază în funcție de sexul animalului.
This DNA test detects the mutation associated with Canine Scott Syndrome in order to identify clear, carrier, or at-risk animals.
Testarea ADN îi ajută pe crescători să planifice împerecheri mai sigure și să reducă riscul de transmitere a mutației către descendenți.
Modul de moștenire raportat pentru acest test este autosomal recesiv.
This test analyses the mutation ANO6 c.1934+1G>A.
Nu neapărat. Interpretarea depinde de modelul de moștenire și de genotipul rezultat.
Brooks M B, Catalfamo J L, MacNguyen R, Tim D, Fancher S, McCardle J A. A TMEM16F point mutation causes an absence of canine platelet TMEM16F and ineffective activation and death-induced phospholipid scrambling. J Thromb Haemost. 2015 Dec;13(12):2240-52. doi: 10.1111/jth.13157. Epub 2015 Nov 20.
Intimitatea ta, alegerea ta
Folosim cookie-uri esențiale pentru a rula site-ul web. Cookie-urile opționale (cum ar fi furnizorii de conținut încorporat) sunt dezactivate în mod implicit și sunt activate numai dacă sunteți de acord. Vă puteți modifica oricând alegerea folosind butonul „Cookies”.
Necesar pentru funcțiile de bază și securitate. Întotdeauna activat.
Îmbunătățește funcții precum salvarea preferințelor sau încorporarea fără publicitate.
Ne ajută să înțelegem utilizarea site-ului. Dezactivat implicit.
Publicitate/urmărire pe site-uri (unele videoclipuri/hărți încorporate). Dezactivat implicit.